stars 1 stars 2 stars 3

The Discure System is designed to treat and reverse degenerative disc disease (DDD), healing the disc, reducing pain, and restoring function to patients, via a minimally invasive, implantable bioelectronic approach. Unlike existing treatments, that are symptom-focused, the Discure System is a disease-modifying solution, designed to reduce the use of opioids and the need for invasive back surgery. The company received FDA Breakthrough Device Designation, was selected by FDA for the TAP program, and won multiple awards including for “Best New Technology in Spine Care” at the North American Spine Society (NASS) annual meeting, by a panel of KOL spinal surgeons and neurosurgeons.

Discure Technologies Questions

Yuval Mandelbaum is the CEO of Discure Technologies.

7 people are employed at Discure Technologies.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users